伐度司他(Vafseo)在哪里可以买到

Valostat is mainly used to treat anemia in patients with dialysis-dependent chronic kidney disease (CKD). It improves anemia symptoms by regulating erythropoietin (EPO) and iron metabolism. This article will analyze its purchase channels, correct dosage methods, and daily care points for patients with chronic kidney disease.

Where can I buy Vafseo?

Vadostat has not been approved by the China National Medical Products Administration and cannot be purchased in domestic hospitals or pharmacies. Patients can go to medical institutions in listed countries to purchase it with a prescription, or they can order online through a compliant cross-border medical platform.

The main reason why vadostat is not commercially available in China is that the clinical trials and approval process have not yet been completed, and the clinical data of Chinese patients need to be further evaluated. When purchasing, you must choose a formal platform that supports drug traceability to avoid purchasing ineffective or substandard drugs.

How to take Vafseo

Correct medication is crucial to control anemia and reduce side effects. The following is the key guidance:

Recommended dosage and administration

The starting dose for adult patients is 300 mg per day. The tablet must be swallowed whole and cannot be cut or chewed. If you miss a dose, you do not need to take it again. You can continue taking the medicine as originally planned the next day. It is recommended to fix the daily medication time to avoid missing doses that may affect the efficacy. If you need to take iron-containing medicines together, they need to be taken at least 1 hour apart.

Dose adjustment standards

Hemoglobin needs to be monitored every 2 weeks during treatment, and the target value is ≤11g/dL. If the Hb rising rate is >1g/dL/2 weeks or Hb is >11g/dL, medication needs to be suspended and the dose reduced to 150 mg/day after Hb drops to the target range. Those who are ineffective after 24 weeks of treatment need to stop taking the drug and re-evaluate the cause.

Liver function monitoring requirements

Monthly testing of ALT, AST and bilirubin is required before treatment and 6 months before medication. If ALT/AST is >3 times the normal value or accompanied by jaundice, the drug needs to be permanently discontinued and hepatoprotective treatment required. Mild abnormalities can maintain the dose, but the monitoring interval needs to be shortened to every 2 weeks.

Daily care for patients with chronic kidney disease

Scientific nursing can delay the progression of the disease and improve the quality of life. The following are specific suggestions:

Diet and fluid control

Adopt a low-salt, low-phosphorus diet, limit the intake of processed foods and carbonated drinks, choose eggs and fish as high-quality protein sources, and dialysis patients need to strictly control the amount of water they drink.

Complication prevention and management

Monitor blood pressure daily and take antihypertensive drugs regularly. Regularly test blood potassium and blood phosphorus to avoid hyperkalemia or renal bone disease. People with itchy skin can use a mild moisturizer to avoid infection caused by scratching.

Psychological support and moderate exercise

Chronic kidney disease can easily cause anxiety or depression. Family members should encourage patients to participate in social activities and seek help from a psychologist if necessary. Daily light exercise (such as walking for 30 minutes) can improve cardiopulmonary function, but strenuous activities need to be avoided. Dialysis patients can try meditation or deep breathing exercises to relieve stress.

Valostat is contraindicated in pregnant women, lactating women, and patients with kidney disease who are not receiving dialysis. Its use is not recommended in children and adolescents due to lack of safety data. Elderly patients do not need to adjust the dosage, but they need to strengthen cardiovascular and liver function monitoring.